Patent · US Active

Composition and method to enhance expression of human defensin 2

US10653714B2 · kind B2 · utility

0Cited by

2References

5Claims

0Family size

Assignee

The Cleveland Clinic Foundation · US

Inventors

Carol de la Motte · Broadview Heights, US
Sean Kessler · Rocky River, US
David Hill · London, CA

Key dates

Filing date	Oct 31, 2017
Grant date	May 19, 2020
Priority date	—
Expiry date	Oct 31, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/644
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions and methods are provided for enhancing the expression of human beta defensin 2 (HBD2) in human colon epithelium cells. The method comprises orally administering a composition comprising hyaluronan, where said hyaluronan has a molecular weight within the range of about 35 kDa.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.